Chronic treatment of male rats with daidzein and 17β-oestradiol induces the contribution of EDHF to endothelium-dependent relaxation

British Journal of Pharmacology

Volumn 141, Issue 2, 2004, Pages 322-328

  Woodman, Owen L ^a   Boujaoude, Mirna ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Daidzein; EDHF; Endothelium; NO; Oestrogen; Potassium channels

Indexed keywords

6 (2 PROPARGYLOXYPHENYL)HEXANOIC ACID; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; BARIUM; CALCIUM ION; CHARYBDOTOXIN; CYTOCHROME P450; DAIDZEIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ESTRADIOL; HEMOGLOBIN; HEXANOIC ACID DERIVATIVE; IBERIOTOXIN; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ION CONDUCTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING;

ANIMALS; BIOLOGICAL FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ESTRADIOL; ISOFLAVONES; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 1342280329     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705603     Document Type: Article

References (32)

1. ANDERSON, H.L., WEIS, J.U., FJALLAND, B. & KORSGAARD, N. (1999). Effect of acute and long-term treatment with 17β-estradiol on the vasomotor responses in the rat aorta. Br. J. Pharmacol., 126, 159-168.
2. ANTHONY, M.S., CLARKSON, T.B., HUGHES, C.L., MORGAN, T.M. & BURKE, G.L. (1996). Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr., 126, 43-50.
3. + channel on pig coronary artery endothelial cells. J. Physiol., 504 (Part 3), 537-543.
4. BERAL, V., BANKS, E. & REEVES, G. (2002). Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet, 360, 942-944.
5. BOLEGO, C., CIGNARELLA, A., RUZZA, R., ZAAROUR, C., MESSI, E., ZANISI, M. & PUGLISI, L. (1997). Differential effects of low-and high-dose estrogen treatments on vascular responses in female rats. Life Sci., 60, 2291-2302.
6. BUSSE, R., EDWARDS, G., FELETOU, M., FLEMING, I., VANHOUTTE, P.M. & WESTON, A.H. (2002). EDHF: bringing the concepts together. Trends Pharmacol. Sci., 23, 374-380.
7. GARLAND, C.J., PLANE, F., KEMP, B.K. & COCKS, T.M. (1995). Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci., 16, 23-30.
8. GERBER, R.T., ANWAR, M.A. & POSTON, L. (1998). Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: an important role for endothelium-derived hyperpolarizing factor (EDHF). Br. J. Pharmacol., 125, 455-460.
9. GOLDING, E.M. & KEPLER, T.A. (2001). Role of estrogen in modulating EDHF-mediated dilations in the female rat middle cerebral artery. Am. J. Physiol., 280, H2417-H2423.
10. GRADY, D., HERRINGTON, D., BITTNER. V., BLUMENTHAL, R., DAVIDSON, M., HLATKY, M., HSIA, J., HULLEY, S., HERD, A., KHAN, S., NEWBY, L.K., WATERS, D., VITTINGHOFF, E. & WENGER, N. (2002). Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/ progestin replacement study follow-up (HERS II). JAMA, 288, 49-57.
11. 2+ entry in porcine aortic endothelial cells. Br. J. Pharmacol., 121, 1579-1588.
12. HUANG, A., SUN, D., CARROLL, M.A., JIANG, H., SMITH, C.J., CONNETTA, J.A., FALCK, J.R., SHESELY, E.G., KOLLER, A. & KALEY, G. (2001). EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice. Am. J. Physiol. Heart Circ. Physiol., 280, H2462-H2469.
13. KARAMSETTY, M.R., KLINGER, J.R. & HILL, N.S. (2001). Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats. J. Pharmacol. Exp. Therap., 297, 968-974.
14. KOH, K. (2002). Effects of estrogen on the vascular wall: vasomotor function and inflammation. Cardiovasc. Res., 55, 714.
15. KUIPER, G.G., LEMMEN, J.G., CARLSSON, B., CORTON, J.C., SAFE, S.H., VAN DER SAAG, P.T., VAN DER BURG, B. & GUSTAFSSON, J.A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4263.
16. LIU, M.Y., HATTORI, Y., FUKAO, M., SATO, A., SAKUMA, I. & KANNO, M. (2001). Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. Br. J. Pharmacol., 132, 1035-1046.
17. MARCHENKO, S.M. & SAGE, S.O. (1996). Calcium-activated potassium channels in the endothelium of intact rat aorta. J. Physiol., 492, 53-60.
18. MCCULLOCH, A.I. & RANDALL, M.D. (1998). Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric vascular bed. Br. J. Pharmacol., 123, 1700-1706.
19. MENDELSOHN, M.E. (2002). Genomic and nongenomic effects of estrogen in the vasculature. Am. J. Cardiol., 90, 3F-6F.
20. MENDELSOHN, M.E. & KARAS, R.H. (1999). The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med., 340, 1801-1811.
21. MITCHELL, J.H., CAWOOD, E., KINNIBURGH, D., PROVAN, A., COLLINS, A.R. & IRVINE, D.S. (2001). Effect of a phytoestrogen food supplement on reproductive health in normal males. Clin. Sci., 100, 613-618.
22. NESTEL, P. (2003). Isoflavones: their effects on cardiovascular risk and functions. Curr. Opin. Lipidol., 14, 3-8.
23. Ca, channel diversity and smooth muscle cell function. Circ. Res., 85, e33-e43.
24. PAK, K.J., GEARY, G.G., DUCKLES, S.P. & KRAUSE, D.N. (2002). Male-female differences in the relative contribution of endothelial vasodilators released by rat tail artery. Life Sci., 71, 1633-1642.
25. QUIGNARD, J.F., FELETOU, M., EDWARDS, G., DUHAULT, J., WESTON, A.H. & VANHOUTTE, P.M. (2000). Role of endothelial cell hyperpolarization in EDHF-mediated responses in the guineapig carotid artery. Br. J. Pharmacol., 129, 1103-1112.
26. SATO, A., MIURA, H., LIU, Y., SOMBERG, L.B., OTTERSON, M.F., DEMEURE, M.J., SCHULTE, W.J., EBERHARDT, L.M., LOBERIZA, F.R., SAKUMA, I. & GUTTERMAN, D.D. (2002). Effect of gender on endothelium-dependent dilation to bradykinin in human adipose microvessels. Am. J. Physiol. Heart Circ. Physiol., 283, H845-H852.
27. SQUADRITO, F., ALTAVILA, D., SQUADRITO, G., SAITTA, A., CUCINOTTA, D., MINUTOLI, L., DEODATO, B., FERLITO, M., CAMPO, G.M., BOVA, A. & CAPUTI, A.P. (2000). Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc. Res., 45, 454-462.
28. SQUADRITO, F., ALTAVILLA, D., MORABITO, N., CRISAFULLI, A., D'ANNA, R., CORRADO, F., RUGGERI, P., CAMPO, G.M., CALAPAI, G., CAPUTI, A.P. & SQUADRITO, G. (2002). The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis, 163, 339-347.
29. SUN, D., HUANG, A., SMITH, C.J., STACKPOLE, C.J., CONNETTA, J.A., SHESELY, E.G., KOLLER, A. & KALEY, G. (1999). Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. Circ. Res., 85, 288-293.
30. WANG, M.H., BRAND-SCHIEBER, E., ZAND, B.A., NGUYEN, X., FALCK, J.R., BALU, N. & SCHWARTZMAN, M.L. (1998). Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J. Pharmacol. Exp. Ther., 284, 966-973.
31. WRITING GROUP FOR THE WOMENS HEALTH INITIATIVE INVESTIGATORS (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.
32. WU, Y., HUANG, A., SUN, D., FALCK, J.R., KOLLER, A. & KALEY, G. (2001). Gender-specific compensation for the lack of NO in the mediation of flow-induced arteriolar dilation. Am. J. Physiol. Heart Circ. Physiol., 280, H2456-H2461.